Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: Safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study

Ali Seddighzadeh, Serena Hung, Krzysztof Selmaj, Yue Cui, Shifang Liu, Bjoern Sperling, Peter A. Calabresi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: Safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds